This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
₹4,479
Share price
0.00%
Change (1 day)
38.43%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -₹143.37
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -₹162.83. In 2021 the company made an earnings per share (EPS) of -₹162.83 a decrease over its 2020 EPS that were of -₹69.79.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -₹143.37 | -11.95% |
| 2021 | -₹162.83 | 133.33% |
| 2020 | -₹69.79 | -16.49% |
| 2019 | -₹83.57 | 27.63% |
| 2018 | -₹65.48 | -305.41% |
| 2017 | ₹31.88 | -142.53% |
| 2016 | -₹74.96 | -19.44% |
| 2015 | -₹93.05 | -0% |
| 2014 | -₹93.05 | 13.68% |
| 2013 | -₹81.85 | -16.67% |
| 2012 | -₹98.22 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | ₹1,590 | -1,076.72% | 🇺🇸 USA |
 | ₹317.11 | -294.74% | 🇺🇸 USA |
 | ₹301.61 | -285.22% | 🇬🇧 UK |
 | ₹342.04 | -310.05% | 🇺🇸 USA |
 | ₹1,214 | -845.25% | 🇺🇸 USA |
 | ₹1,219 | -848.68% | 🇺🇸 USA |
 | ₹160.25 | -198.41% | 🇺🇸 USA |
 | -₹172.31 | 5.82% | 🇮🇱 Israel |
 | ₹156.95 | -196.39% | 🇺🇸 USA |